Next Article in Journal
The Efficacy and Safety Associated with Switching from Concomitant Brimonidine and Ripasudil, or Brimonidine or Ripasudil Monotherapy to a Fixed Combination of Brimonidine and Ripasudil in Glaucoma Patients
Previous Article in Journal
Poor Sperm Chromatin Condensation Is Associated with Cryopreservation-Induced DNA Fragmentation and Cell Death in Human Spermatozoa
Previous Article in Special Issue
Comment on Salazar et al. Weight Regain after Metabolic Surgery: Beyond the Surgical Failure. J. Clin. Med. 2024, 13, 1143
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Reply

Reply to Pantelis, A.G. Comment on “Salazar et al. Weight Regain after Metabolic Surgery: Beyond the Surgical Failure. J. Clin. Med. 2024, 13, 1143”

1
Endocrine and Metabolic Diseases Research Center, School of Medicine, University of Zulia, Maracaibo 4004, Venezuela
2
Facultad de Ciencias de la Salud, Universidad Simón Bolívar, Barranquilla 080001, Colombia
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2024, 13(14), 4157; https://doi.org/10.3390/jcm13144157
Submission received: 3 July 2024 / Accepted: 15 July 2024 / Published: 16 July 2024
(This article belongs to the Special Issue Clinical Advances in Obesity and Bariatric Surgery)
We want to express our sincere gratitude for Dr. Pantelis’ time and interest in reviewing our article and providing valuable feedback. Dr. Pantelis’ insightful comments [1] have undoubtedly helped us improve the quality and accuracy of our work.
  • Regarding the terms and definitions of “weight regain” and “surgical failure”:
We wholeheartedly agree with your assessment regarding the need to redefine and refocus these concepts in light of the growing recognition of obesity as a chronic disease. As outlined in the ASMBS statement [2], standardizing the nomenclature, similar to that used in oncology, would be crucial to establishing universal and specific definitions in post-surgical care. As you rightly point out, this would allow for more precise epidemiological estimates and facilitate comparisons of outcomes across different studies.
  • Concerning the complication rates:
It is true that with the advancement of surgical techniques over the years, there has been a significant decline in both short- and long-term complication rates, particularly in reoperations. This fact is corroborated by short- and medium-term analyses of patients undergoing One Anastomosis Gastric Bypass, especially as a primary procedure [3].
However, it is noteworthy that the complication rates presented in our review are largely consistent with those reported in recent meta-analyses, such as those by Chungyoon Kim [4] and Balamurugan [5], regarding early complications. In this sense, the Clavien–Dindo classification allows the standardization of definitions of complications.
  • On the role of bariatric surgery in the “weight set-point”:
While bariatric surgery is considered a factor that can potentially alter the “weight set-point,” it is important to emphasize that, to date, no definitive clinical models substantiate this theory. In this regard, post-bariatric weight recurrence could represent an ideal clinical setting to evaluate the role of the potential mechanisms involved in the regulation of body weight and the gut–brain axis.
  • Preoperative predictors of weight recurrence:
Although our review primarily focuses on the post-operative mechanisms of weight recurrence, it is important to acknowledge the existence of various preoperative predictors, including genetic predisposition, preoperative weight loss, and insulin sensitivity, among others [6]. In this context, the preoperative metabolic phenotype emerges as a potential predictor to consider in the clinical setting.
Once again, we appreciate your valuable comments and hope this response has addressed your concerns. We remain at your disposal for any further inquiries.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pantelis, A.G. Comment on Salazar et al. Weight Regain after Metabolic Surgery: Beyond the Surgical Failure. J. Clin. Med. 2024, 13, 1143. J. Clin. Med. 2024, 13, 3608. [Google Scholar] [CrossRef] [PubMed]
  2. Majid, S.F.; Davis, M.J.; Ajmal, S.; Podkameni, D.; Jain-Spangler, K.; Guerron, A.D.; King, N.; Voellinger, D.C.; Northup, C.J.; Kennedy, C.; et al. Current state of the definition and terminology related to weight recurrence after metabolic surgery: Review 96 by the POWER Task Force of the American Society for Metabolic and Bariatric Surgery. Surg. Obes. Relat. Dis. Off. J. Am. Soc. 97 Bariatr. Surg. 2022, 18, 957–963. [Google Scholar] [CrossRef] [PubMed]
  3. Hailstone, L.; Tovmassian, D.; Nguyen, C.L.; Wong, P.; Le Page, P.A.; Martin, D.; Taylor, C. Medium-Term Outcomes from a Series of 1000 One Anastomosis Gastric Bypass in Australia: A Case Series. Obes. Surg. 2024, 34, 2111–2115. [Google Scholar] [CrossRef] [PubMed]
  4. Chungyoon, K.J. Outcomes and Adverse Events After Bariatric Surgery: An Updated Systematic Review and Meta-analysis, 2013–2023. J. Metab. Bariatr. Surg. 2023, 12, 76–88. [Google Scholar]
  5. Balamurugan, G.; Leo, S.J.; Sivagnanam, S.T.; Balaji Prasad, S.; Ravindra, C.; Rengan, V.; Arora, E.; Bindal, V. Comparison of Efficacy and Safety Between Roux-en-Y Gastric Bypass (RYGB) vs One Anastomosis Gastric Bypass (OAGB) vs Single Anastomosis Duodeno-ileal Bypass with Sleeve Gastrectomy (SADI-S): A Systematic Review of Bariatric and Metabolic Surgery. Obes. Surg. 2023, 33, 2194–2209. [Google Scholar] [CrossRef] [PubMed]
  6. Demerdash, H.M. Weight regain after bariatric surgery: Promoters and potential predictors. World J. Meta-Anal. 2021, 9, 438–454. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Salazar, J.; Bermúdez, V. Reply to Pantelis, A.G. Comment on “Salazar et al. Weight Regain after Metabolic Surgery: Beyond the Surgical Failure. J. Clin. Med. 2024, 13, 1143”. J. Clin. Med. 2024, 13, 4157. https://doi.org/10.3390/jcm13144157

AMA Style

Salazar J, Bermúdez V. Reply to Pantelis, A.G. Comment on “Salazar et al. Weight Regain after Metabolic Surgery: Beyond the Surgical Failure. J. Clin. Med. 2024, 13, 1143”. Journal of Clinical Medicine. 2024; 13(14):4157. https://doi.org/10.3390/jcm13144157

Chicago/Turabian Style

Salazar, Juan, and Valmore Bermúdez. 2024. "Reply to Pantelis, A.G. Comment on “Salazar et al. Weight Regain after Metabolic Surgery: Beyond the Surgical Failure. J. Clin. Med. 2024, 13, 1143”" Journal of Clinical Medicine 13, no. 14: 4157. https://doi.org/10.3390/jcm13144157

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop